Latest Capital Raises News

Sarama Resources posted a US$2.27 million nine-month profit after selling its Western Australian gold projects, but the gain was largely accounting-based and management says further funding is required. Cash stood at US$619,667 as the company advances a US$245.3 million Burkina Faso arbitration claim.

Paladin Energy has completed the bookbuild for a fully underwritten A$525 million equity raising, with strong demand lifting the ASX placement to A$499 million. The funding is aimed at advancing Patterson Lake South, extending Triple R and expanding exploration across Canada’s Athabasca Basin.

Talonx Resources has launched a non-underwritten share purchase plan targeting up to A$1 million from eligible Australian and New Zealand shareholders at A$0.005 a share. The funds are earmarked for expanded copper and base-metals exploration in Botswana, further gold drilling in Western Australia and working capital.

OpenLearning has secured a $500,000 investment from Philippine conglomerate World Citi Group, lifting commitments to its capital raising to approximately $1.48 million. The deal adds a potential technology partnership to a funding effort backed by record SaaS growth, but the larger entitlement offer still depends on shareholder participation.

Wide Open Agriculture has secured a $1 million placement to fund manufacturing trials, commercial development and working capital as it targets a return to lupin ingredient production in Q2 2027. The raise strengthens its cash position, but production still depends on selecting a partner and completing technical validation.

Neurizon’s first participant in the 250-person Regimen I ALS trial has completed the 36-week randomised phase and entered an optional active treatment extension. The milestone keeps the program on track for topline results in late Q2 2027, while recent FDA feedback points to a potential single-trial approval pathway if the data meet regulatory standards.

Xenora Minerals is acquiring the Errolls Gold and Limestone Well projects in Western Australia, creating a 115-square-kilometre exploration package beside Solstice Minerals’ Nanadie copper-gold discovery. The deal comes with a A$5 million placement, a new executive chair and an ambitious drilling program, but completion and exploration success remain unproven.

Far East Gold’s A$0.10 Share Purchase Plan remains open after the Supreme Court of New South Wales dismissed Xingye Gold’s application for an urgent final hearing. The next legal test arrives on 20 November, when Xingye is due to seek interlocutory injunctive relief.

Kincora Copper has used a US$10 million Mongolian asset sale and AngloGold Ashanti-backed exploration to broaden its New South Wales copper-gold portfolio. The quarter ended with approximately A$13 million in cash, but the unaudited accounts still flag material uncertainty over ongoing funding.

RBR Group has secured A$600,000 through a placement and reworked all A$1.25 million of its convertible notes, giving it near-term funding to deliver its first post-restart Rovuma LNG contract. The financing strengthens the bridge to execution, but leaves shareholders facing further dilution and the company still dependent on future awards.

Imricor Medical Systems (ASX:IMR) has moved from regulatory preparation into US commercial deployment, signing its first two NorthStar hospital customers within weeks of launch. The milestone comes with sharply higher quarterly revenue, a fresh Philips pathway and a still-heavy cash burn.

Lendlease has begun the process of redeeming approximately $1.22 billion of outstanding bonds, funded by a $1.25 billion standby facility secured in June. The transaction is expected to leave the group with more than $2.5 billion in liquidity, but will incur about $57 million in non-recurring financing costs.